Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

LFCRLFCR
Showing 8 of 23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in LIFECORE BIOMEDICAL INC

Bank of New York Mellon Corp holds 67,272 shares of LFCR (LIFECORE BIOMEDICAL INC), worth $353,178 as of 2026-Q2. The position was increased (+15.1% shares). LFCR represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$353,178

Current Shares

67,272

Total Value Change

+$122,050

Total Shares Change

+20,390

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
67,272
+15.1%
$353,1780.0%$5.25
27
2026-Q1
Decreased
58,466
-0.7%
$217,4930.0%$6.99
0
2025-Q4
Decreased
58,888
-30.6%
$481,7040.0%$8.09
0
2025-Q3
Increased
84,863
+2.1%
$624,5920.0%$7.15
25
2025-Q2
Decreased
83,076
-0.7%
$674,5770.0%$8.19
0
2025-Q1
Increased
83,663
+3.8%
$588,9870.0%$6.85
25
2024-Q4
Increased
80,572
+71.9%
$598,6500.0%$7.42
36
2024-Q3
Decreased
46,882
-26.5%
$231,1280.0%$4.95
0

Other major holders of LFCR: BNP PARIBAS FINANCIAL MARKETS, Russell Investments Group, Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used